Research, methods and collaboration

1981–2020

Hepatitis C 1997: Testing Infectious RNA

Examine Rice and colleagues’ 1997 functional evidence through sequence association, biological outcomes and negative-result limits, with an original causality exercise.

Original explanatory diagram: Hepatitis C 1997: Testing Infectious RNA

The short answer

What did a defined RNA-transcript inoculation test establish beyond detecting a viral sequence or antibody marker?

Read the evidence

Different records within the same investigation

The following comparison distinguishes the specific questions answered by the inspected records.

Original comparison of inspected records; the worked example is an editorial teaching exercise.
Record or testWhat it establishesWhat remains different
AssociationConnects material with affected samples.Does not alone demonstrate functional causation.
Functional evidenceTests an attributed biological capability.Must be interpreted within the investigated system.
Multiple outcomesConstrain the relation between agent and disease.Need separate identification and comparison.

A recognised sequence left a further causal question

Molecular identification had linked HCV genetic material with non-A, non-B hepatitis. The next question was whether defined viral RNA could account for infection and disease in a tested biological system. The 1997 Rice-team paper addressed that stronger functional claim. It did not merely seek another association between a patient sample and a molecular marker. A useful history therefore distinguishes identifying material related to the disease from testing whether that material can initiate the biological process attributed to it.

Sources for this section: [1] · [2]

Several outcomes supplied complementary evidence

Rice’s lecture describes changes in viral RNA, liver-enzyme measurements and tissue findings after the successful experiment. Those observations addressed different parts of the causal account. Detecting molecular material alone would not necessarily establish productive infection or the related tissue outcome. Conversely, a nonspecific disease indicator alone would not establish the identity of the responsible agent. Their combination made the interpretation more specific. This guide explains the evidential relationship without supplying viral construction, delivery, production or propagation procedures.

Sources for this section: [3]

Earlier failure had several possible interpretations

The first-person lecture also recounts unsuccessful attempts before the 1997 result. A negative outcome could reflect limitations in the tested material or the biological system rather than the universal impossibility of the proposed causal relationship. That does not make all failures meaningless; it means the conclusion must be limited to the comparison actually made. Distinguishing a failed test from a demonstrated absence of causal capability is especially important when the relevant functional system has not yet been independently established.

Sources for this section: [3]

The discovery was a sequence of contributions

Rockefeller’s institutional record connects Rice’s functional evidence with the broader hepatitis C programme, while the Nobel record recognises Alter, Houghton and Rice together. Clinical exclusion, molecular cloning and functional infection addressed related but separate questions. The chronology supplies an explanatory structure: each result reduced a different uncertainty left by earlier work. The collaboration also extended beyond the three laureates, as the original study’s authorship shows. Award summaries should therefore introduce the programme without replacing its specific experimental and credit record.

Sources for this section: [2] · [4] · [1]

An original causal-evidence exercise and answer

Imagine three fictional records. A identifies sequence S more often in affected samples. B links defined S-related material with a reproducible biological process. C observes a relevant tissue outcome alongside that process. Which record alone establishes the entire chain? None, as stated. A concerns association; B addresses function in a tested context; C helps connect that function with an outcome. These letters are teaching labels and contain no infectious-material instructions. A strong answer asks which controls distinguish alternative causes and which observation measures each link. It also resists interpreting an unsuccessful preliminary B as proof that S could never matter. The lesson is to connect evidence at the right level, rather than granting one molecular observation every later causal conclusion.

Sources for this section: [1] · [3] · [2]

Continue the chronology

Biography context

Explore United States through connected lives

Connected biographies

Researchers and related approaches

United StatesCulture

1952–

Charles M. Rice

Virologist and RNA-virus researcherCharles Rice investigated RNA viruses and helped establish functional hepatitis C genome evidence, connecting molecular identification with experimental infectivity.Read biography
United StatesCulture

1912–1991

Salvador Luria

Microbiologist and scientific institution builderSalvador Luria studied bacterial viruses, helped establish microbial genetics and later combined research leadership at MIT with public political engagement.Read biography

Quick answers

Common questions

Does sequence association equal functional infection?
No. They answer different questions.
Does one failed functional test disprove every causal role?
No. Material and system limitations must be considered.

Primary and institutional sources

How this history was checked

The references below distinguish the original study from later explanations. The worked exercise and comparison are newly written for this article. This article was reviewed on 8 November 2026.

  1. Kolykhalov, Agapov, Blight, Mihalik, Feinstone and Rice, Science, 1997Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
  2. The Rockefeller University, 5 October 2020Rockefeller’s Charles M. Rice honored with Nobel Prize for research that contributed to a cure for hepatitis C
  3. Nobel Prize OutreachCharles M. Rice — Nobel lecture
  4. Nobel Prize OutreachCharles M. Rice — Facts
  5. Nobel Prize OutreachCharles M. Rice — Biographical